| Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid S Kataoka, K Takuma, Y Hara, Y Maeda, Y Ago, T Matsuda International journal of Neuropsychopharmacology 16 (1), 91-103, 2013 | 338 | 2013 |
| Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and … K Koda, Y Ago, Y Cong, Y Kita, K Takuma, T Matsuda Journal of neurochemistry 114 (1), 259-270, 2010 | 245 | 2010 |
| Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism K Takuma, Y Hara, S Kataoka, T Kawanai, Y Maeda, R Watanabe, ... Pharmacology biochemistry and behavior 126, 43-49, 2014 | 133 | 2014 |
| Pharmacological aspects of the acetylcholinesterase inhibitor galantamine Y Ago, K Koda, K Takuma, T Matsuda Journal of pharmacological sciences 116 (1), 6-17, 2011 | 133 | 2011 |
| mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants S Chaki, Y Ago, A Palucha-Paniewiera, F Matrisciano, A Pilc Neuropharmacology 66, 40-52, 2013 | 129 | 2013 |
| High-speed and scalable whole-brain imaging in rodents and primates K Seiriki, A Kasai, T Hashimoto, W Schulze, M Niu, S Yamaguchi, ... Neuron 94 (6), 1085-1100. e6, 2017 | 114 | 2017 |
| Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression Y Ago, S Arikawa, M Yata, K Yano, M Abe, K Takuma, T Matsuda Neuropharmacology 55 (8), 1355-1363, 2008 | 113 | 2008 |
| Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice Y Ago, K Yano, R Araki, N Hiramatsu, Y Kita, T Kawasaki, H Onoe, ... Neuropharmacology 65, 29-38, 2013 | 100 | 2013 |
| Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice K Tanaka, N Shintani, H Hashimoto, N Kawagishi, Y Ago, T Matsuda, ... Journal of Neuroscience 26 (19), 5091-5097, 2006 | 98 | 2006 |
| Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice H Yamaguchi, Y Hara, Y Ago, E Takano, S Hasebe, T Nakazawa, ... Behavioural brain research 333, 67-73, 2017 | 92 | 2017 |
| Galantamine promotes adult hippocampal neurogenesis via M1 muscarinic and α7 nicotinic receptors in mice Y Kita, Y Ago, K Higashino, K Asada, E Takano, K Takuma, T Matsuda International Journal of Neuropsychopharmacology 17 (12), 1957-1968, 2014 | 91 | 2014 |
| Nitric oxide‐induced apoptosis in cultured rat astrocytes: Protection by edaravone, a radical scavenger T Kawasaki, T Kitao, K Nakagawa, H Fujisaki, Y Takegawa, K Koda, ... Glia 55 (13), 1325-1333, 2007 | 85 | 2007 |
| Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex Y Ago, Y Koyama, A Baba, T Matsuda Neuropharmacology 45 (8), 1050-1056, 2003 | 81 | 2003 |
| Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes K Matsumura, K Seiriki, S Okada, M Nagase, S Ayabe, I Yamada, ... Nature communications 11 (1), 859, 2020 | 77 | 2020 |
| Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice T Ishihama, Y Ago, N Shintani, H Hashimoto, A Baba, K Takuma, ... Behavioural brain research 209 (2), 274-280, 2010 | 77 | 2010 |
| Modulation by 5-HT2A receptors of aggressive behavior in isolated mice M Sakaue, Y Ago, C Sowa, Y Sakamoto, B Nishihara, Y Koyama, A Baba, ... Japanese journal of pharmacology 89 (1), 89-92, 2002 | 77 | 2002 |
| Effect of prenatal valproic acid exposure on cortical morphology in female mice Y Hara, Y Maeda, S Kataoka, Y Ago, K Takuma, T Matsuda Journal of pharmacological sciences 118 (4), 543-546, 2012 | 73 | 2012 |
| (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism Y Ago, W Tanabe, M Higuchi, S Tsukada, T Tanaka, T Yamaguchi, ... International Journal of Neuropsychopharmacology 22 (10), 665-674, 2019 | 72 | 2019 |
| Distribution of silver nanoparticles to breast milk and their biological effects on breast-fed offspring mice Y Morishita, Y Yoshioka, Y Takimura, Y Shimizu, Y Namba, N Nojiri, ... ACS nano 10 (9), 8180-8191, 2016 | 70 | 2016 |
| Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice Y Ago, S Nakamura, M Uda, Y Kajii, M Abe, A Baba, T Matsuda Neuropharmacology 51 (4), 914-922, 2006 | 66 | 2006 |
